Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Siga Technologies Inc (SIGA)

Siga Technologies Inc (SIGA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Siga Technologies Inc 31 EAST 62ND STREET NEW YORK NY 10065 USA

www.siga.com P: 212-672-9100 F: 212-697-3130

Description:

SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.

Key Statistics

Overview:

Market Capitalization, $K 560,449
Enterprise Value, $K 410,299
Shares Outstanding, K 71,123
Annual Sales, $ 139,920 K
Annual Net Income, $ 68,070 K
Last Quarter Sales, $ 21,810 K
Last Quarter Net Income, $ 1,830 K
EBIT, $ 102,730 K
EBITDA, $ 103,270 K
60-Month Beta 0.91
% of Insider Shareholders 1.54%
% of Institutional Shareholders 55.40%
Float, K 70,028
% Float 98.46%
Short Volume Ratio 0.70

Growth:

1-Year Return 75.55%
3-Year Return 15.34%
5-Year Return 56.27%
5-Year Revenue Growth -70.67%
5-Year Earnings Growth -81.37%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.03 on 08/01/24
Next Earnings Date 11/05/24
Earnings Per Share ttm 1.17
EPS Growth vs. Prev Qtr -78.57%
EPS Growth vs. Prev Year 175.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 50.81%

SIGA Ratios

Ratio
Price/Earnings ttm 6.83
Price/Earnings forward 7.82
Price/Earnings to Growth N/A
Return-on-Equity % 51.40%
Return-on-Assets % 39.58%
Profit Margin % 48.65%
Debt/Equity 0.00
Price/Sales 4.08
Price/Cash Flow 8.19
Price/Book 3.36
Book Value/Share 2.35
Interest Coverage 4.98
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar